Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05KBU
|
|||
| Drug Name |
Gabapentin enacarbil
|
|||
| Synonyms |
1838262; ASP8825; Gabapentin-XP; GSK 1838262; Horizant; Regnite; Solzira; XP13512
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alcohol dependence [ICD-11: 6C40.2; ICD-10: F10.2; ICD-9: 303] | Phase 2 | [1] | |
| Therapeutic Class |
Neurology Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H27NO6
|
|||
| Canonical SMILES |
CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O
|
|||
| InChI |
1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)
|
|||
| InChIKey |
TZDUHAJSIBHXDL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 478296-72-9
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:68840
|
|||
| ADReCS Drug ID | BADD_D00982 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium-dependent multivitamin transporter (SLC5A6) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.